Saturday, April 18, 2020

NEW DRUG PRODUCT: S

Click here to update/complete your profile, or adjust your account settings.
To unsubscribe from the First Look newsletter, click here
© 2020 Haymarket Media, Inc. | 275 7th Ave, 10th Floor, New York, NY 10001
MPR

NEW DRUG PRODUCT: VYEPTI

FEATURED
Find out more about Vyepti including dosing and important safety information with our slideshow, complete drug monograph, and downloadable PDF.

DRUGS IN THE PIPELINE

VICTORIA Trial: Vericiguat Beneficial in Patients With High-Risk Heart Failure

Dasiglucagon NDA for Severe Hypoglycemia Treatment Submitted to FDA

Epidiolex Gets Priority Review for Tuberous Sclerosis Complex-Associated Seizures

Zimura Gets Fast Track Status for Geographic Atrophy Secondary to Dry AMD

Remestemcel-L Under Review for Steroid-Refractory Acute Graft Versus Host Disease

MPR The right dose
of information.

eMPR.com

Featured Content

Collection and Use of Real-World Data Continues to Grow Around the World

CME/CE Spotlight

A Multidisciplinary Approach to the Management of Psoriatic Arthritis

AMA PRA Category 1 Credit(s)TM, CNE Contact Hour(s), CE for Pharmacists

CLICK HERE FOR A FULL LIST OF COURSES
CE/CME Powered By myCME

No comments:

Post a Comment